The global oligonucleotides market size is calculated at USD 4.79 billion in 2025 and is forecasted to reach around USD 14.54 billion by 2034, accelerating at a CAGR of 13.14% from 2025 to 2034. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Oligonucleotides Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Oligonucleotides Market Revenue and Volume, by Product Type
8.1.1. Therapeutic Oligonucleotides
8.1.1.1. Market Revenue and Volume Forecast
8.1.2. Diagnostic Oligonucleotides
8.1.2.1. Market Revenue and Volume Forecast
8.1.3. Research Oligonucleotides
8.1.3.1. Market Revenue and Volume Forecast
9.1. Oligonucleotides Market Revenue and Volume, by Application
9.1.1. Drug Discovery & Development
9.1.1.1. Market Revenue and Volume Forecast
9.1.2. Molecular Diagnostics
9.1.2.1. Market Revenue and Volume Forecast
9.1.2. Gene Therapy
9.1.2.1. Market Revenue and Volume Forecast
9.1.2. Research Applications (PCR, qPCR, NGS, etc.)
9.1.2.1. Market Revenue and Volume Forecast
9.1.2. RNA-based Therapeutics
9.1.2.1. Market Revenue and Volume Forecast
9.1.2. Cancer & Rare Disease Diagnostics
9.1.2.1. Market Revenue and Volume Forecast
10.1. Oligonucleotides Market Revenue and Volume, by Manufacturing Technology
10.1.1. Solid Phase Oligonucleotide Synthesis
10.1.1.1. Market Revenue and Volume Forecast
10.1.2. Solution Phase Synthesis
10.1.2.1. Market Revenue and Volume Forecast
10.1.3. Microarray-Based Synthesis
10.1.3.1. Market Revenue and Volume Forecast
10.1.4. Enzymatic Synthesis
10.1.4.1. Market Revenue and Volume Forecast
11.1. Oligonucleotides Market Revenue and Volume, by End-User
11.1.1. Pharmaceutical & Biotechnology Companies
11.1.1.1. Market Revenue and Volume Forecast
11.1.2. Academic & Research Institutes
11.1.2.1. Market Revenue and Volume Forecast
11.1.3. Diagnostic Laboratories
11.1.3.1. Market Revenue and Volume Forecast
11.1.4. Contract Research Organizations (CROs)
11.1.4.1. Market Revenue and Volume Forecast
11.1.5. Contract Manufacturing Organizations (CMOs)
11.1.5.1. Market Revenue and Volume Forecast
12.1. Oligonucleotides Market Revenue and Volume, by Delivery Mode
12.1.1. Injectable
12.1.1.1. Market Revenue and Volume Forecast
12.1.2. Oral
12.1.2.1. Market Revenue and Volume Forecast
12.1.3. Intranasal
12.1.3.1. Market Revenue and Volume Forecast
12.1.4. Transdermal
12.1.4.1. Market Revenue and Volume Forecast
13.1. Oligonucleotides Market Revenue and Volume, by Sales Channel
13.1.1. Direct Sales
13.1.1.1. Market Revenue and Volume Forecast
13.1.2. Distributor/Third-Party Sales
13.1.2.1. Market Revenue and Volume Forecast
13.1.3. Online Platforms
13.1.3.1. Market Revenue and Volume Forecast
14.1. North America
14.1.1. Market Revenue and Volume Forecast, by Product Type
14.1.2. Market Revenue and Volume Forecast, by Application
14.1.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.1.4. Market Revenue and Volume Forecast, by End-User
14.1.5. Market Revenue and Volume Forecast, by Delivery Mode
14.1.6. Market Revenue and Volume Forecast, by Sales Channel
14.1.7.1. Market Revenue and Volume Forecast, by Product Type
14.1.7.2. Market Revenue and Volume Forecast, by Application
14.1.7.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.1.7.4. Market Revenue and Volume Forecast, by End-User
14.1.8. Market Revenue and Volume Forecast, by Delivery Mode
14.1.8.1. Market Revenue and Volume Forecast, by Sales Channel
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Volume Forecast, by Product Type
14.1.9.2. Market Revenue and Volume Forecast, by Application
14.1.9.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.1.9.4. Market Revenue and Volume Forecast, by End-User
14.1.10. Market Revenue and Volume Forecast, by Delivery Mode
14.1.11. Market Revenue and Volume Forecast, by Sales Channel
14.2. Europe
14.2.1. Market Revenue and Volume Forecast, by Product Type
14.2.2. Market Revenue and Volume Forecast, by Application
14.2.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.2.4. Market Revenue and Volume Forecast, by End-User
14.2.5. Market Revenue and Volume Forecast, by Delivery Mode
14.2.6. Market Revenue and Volume Forecast, by Sales Channel
14.2.8. UK
14.2.8.1. Market Revenue and Volume Forecast, by Product Type
14.2.8.2. Market Revenue and Volume Forecast, by Application
14.2.8.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.2.9. Market Revenue and Volume Forecast, by End-User
14.2.10. Market Revenue and Volume Forecast, by Delivery Mode
14.2.10.1. Market Revenue and Volume Forecast, by Sales Channel
14.2.11. Germany
14.2.11.1. Market Revenue and Volume Forecast, by Product Type
14.2.11.2. Market Revenue and Volume Forecast, by Application
14.2.11.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.2.12. Market Revenue and Volume Forecast, by End-User
14.2.13. Market Revenue and Volume Forecast, by Delivery Mode
14.2.14. Market Revenue and Volume Forecast, by Sales Channel
14.2.15. France
14.2.15.1. Market Revenue and Volume Forecast, by Product Type
14.2.15.2. Market Revenue and Volume Forecast, by Application
14.2.15.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.2.15.4. Market Revenue and Volume Forecast, by End-User
14.2.16. Market Revenue and Volume Forecast, by Delivery Mode
14.2.16.1. Market Revenue and Volume Forecast, by Sales Channel
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Volume Forecast, by Product Type
14.2.17.2. Market Revenue and Volume Forecast, by Application
14.2.17.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.2.17.4. Market Revenue and Volume Forecast, by End-User
14.2.18. Market Revenue and Volume Forecast, by Delivery Mode
14.2.18.1. Market Revenue and Volume Forecast, by Sales Channel
14.3. APAC
14.3.1. Market Revenue and Volume Forecast, by Product Type
14.3.2. Market Revenue and Volume Forecast, by Application
14.3.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.3.4. Market Revenue and Volume Forecast, by End-User
14.3.5. Market Revenue and Volume Forecast, by Delivery Mode
14.3.6. Market Revenue and Volume Forecast, by Sales Channel
14.3.7. India
14.3.7.1. Market Revenue and Volume Forecast, by Product Type
14.3.7.2. Market Revenue and Volume Forecast, by Application
14.3.7.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.3.7.4. Market Revenue and Volume Forecast, by End-User
14.3.8. Market Revenue and Volume Forecast, by Delivery Mode
14.3.9. Market Revenue and Volume Forecast, by Sales Channel
14.3.10. China
14.3.10.1. Market Revenue and Volume Forecast, by Product Type
14.3.10.2. Market Revenue and Volume Forecast, by Application
14.3.10.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.3.10.4. Market Revenue and Volume Forecast, by End-User
14.3.11. Market Revenue and Volume Forecast, by Delivery Mode
14.3.11.1. Market Revenue and Volume Forecast, by Sales Channel
14.3.12. Japan
14.3.12.1. Market Revenue and Volume Forecast, by Product Type
14.3.12.2. Market Revenue and Volume Forecast, by Application
14.3.12.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.3.12.4. Market Revenue and Volume Forecast, by End-User
14.3.12.5. Market Revenue and Volume Forecast, by Delivery Mode
14.3.12.6. Market Revenue and Volume Forecast, by Sales Channel
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Volume Forecast, by Product Type
14.3.13.2. Market Revenue and Volume Forecast, by Application
14.3.13.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.3.13.4. Market Revenue and Volume Forecast, by End-User
14.3.13.5. Market Revenue and Volume Forecast, by Delivery Mode
14.3.13.6. Market Revenue and Volume Forecast, by Sales Channel
14.4. MEA
14.4.1. Market Revenue and Volume Forecast, by Product Type
14.4.2. Market Revenue and Volume Forecast, by Application
14.4.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.4.4. Market Revenue and Volume Forecast, by End-User
14.4.5. Market Revenue and Volume Forecast, by Delivery Mode
14.4.6. Market Revenue and Volume Forecast, by Sales Channel
14.4.7. GCC
14.4.7.1. Market Revenue and Volume Forecast, by Product Type
14.4.7.2. Market Revenue and Volume Forecast, by Application
14.4.7.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.4.7.4. Market Revenue and Volume Forecast, by End-User
14.4.8. Market Revenue and Volume Forecast, by Delivery Mode
14.4.9. Market Revenue and Volume Forecast, by Sales Channel
14.4.10. North Africa
14.4.10.1. Market Revenue and Volume Forecast, by Product Type
14.4.10.2. Market Revenue and Volume Forecast, by Application
14.4.10.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.4.10.4. Market Revenue and Volume Forecast, by End-User
14.4.11. Market Revenue and Volume Forecast, by Delivery Mode
14.4.12. Market Revenue and Volume Forecast, by Sales Channel
14.4.13. South Africa
14.4.13.1. Market Revenue and Volume Forecast, by Product Type
14.4.13.2. Market Revenue and Volume Forecast, by Application
14.4.13.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.4.13.4. Market Revenue and Volume Forecast, by End-User
14.4.13.5. Market Revenue and Volume Forecast, by Delivery Mode
14.4.13.6. Market Revenue and Volume Forecast, by Sales Channel
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Volume Forecast, by Product Type
14.4.14.2. Market Revenue and Volume Forecast, by Application
14.4.14.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.4.14.4. Market Revenue and Volume Forecast, by End-User
14.4.14.5. Market Revenue and Volume Forecast, by Delivery Mode
14.4.14.6. Market Revenue and Volume Forecast, by Sales Channel
14.5. Latin America
14.5.1. Market Revenue and Volume Forecast, by Product Type
14.5.2. Market Revenue and Volume Forecast, by Application
14.5.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.5.4. Market Revenue and Volume Forecast, by End-User
14.5.5. Market Revenue and Volume Forecast, by Delivery Mode
14.5.6. Market Revenue and Volume Forecast, by Sales Channel
14.5.7. Brazil
14.5.7.1. Market Revenue and Volume Forecast, by Product Type
14.5.7.2. Market Revenue and Volume Forecast, by Application
14.5.7.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.5.7.4. Market Revenue and Volume Forecast, by End-User
14.5.8. Market Revenue and Volume Forecast, by Delivery Mode
14.5.8.1. Market Revenue and Volume Forecast, by Sales Channel
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Volume Forecast, by Product Type
14.5.9.2. Market Revenue and Volume Forecast, by Application
14.5.9.3. Market Revenue and Volume Forecast, by Manufacturing Technology
14.5.9.4. Market Revenue and Volume Forecast, by End-User
14.5.9.5. Market Revenue and Volume Forecast, by Delivery Mode
14.5.9.6. Market Revenue and Volume Forecast, by Sales Channel
15.1. Ionis Pharmaceuticals
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Bio-Synthesis Inc.
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Sarepta Therapeutics
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Bioneer Corporation
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. GE Healthcare
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. TriLink BioTechnologies
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Bio-Techne Corporation
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. Roche Diagnostics
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. GeneDesign, Inc.
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. GenScript Biotech Corporation
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Plan your call and get expert insights!
Schedule a Meeting
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Get a Sample
Report Description
Get a Sample
Report Description